文献速递心境障碍儿童青少年精神

青少年及年轻女性口服避孕药与抑郁症状的关联

Association of Use of Oral Contraceptives With Depressive Symptoms Among Adolescents and Young Women.
PubMed 文献 · JAMA Psychiatry · 2020-01-01

基于TRAILS前瞻性队列研究,分析1010名16至25岁女性口服避孕药使用与抑郁症状的关联。结果显示,所有年龄组合并后无显著关联,但16岁使用者抑郁症状评分高于非使用者,且该关联随年龄增长而减弱。青少年使用者更易报告哭泣、嗜睡和进食问题。

要点

  • 16岁女性使用口服避孕药与抑郁症状评分升高相关,需关注。
  • 口服避孕药与抑郁症状的关联存在年龄差异,青少年更明显。
  • 青少年使用者更易出现哭泣、嗜睡和进食问题等症状。

核心结论

  • 所有年龄组合并时口服避孕药使用与抑郁症状无显著关联,但16岁女孩使用时抑郁症状评分更高。

研究设计与样本

  • 前瞻性队列研究TRAILS第三至第六波,纳入1010名16至25岁女性,每人完成1至4次评估。

主要发现

  • 16岁使用者抑郁症状平均评分0.40(SD 0.30)高于非使用者0.33(SD 0.30)。

临床怎么用

  • 对使用口服避孕药的青少年应监测抑郁症状,因其可能影响生活质量和用药依从性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Oral contraceptives have been associated with an increased risk of subsequent clinical depression in adolescents. However, the association of oral contraceptive use with concurrent depressive symptoms remains unclear. OBJECTIVES: To investigate the association between oral contraceptive use and depressive symptoms and to examine whether this association is affected by age and which specific symptoms are associated with oral contraceptive use. DESIGN, SETTING, AND PARTICIPANTS: Data from the third to sixth wave of the prospective cohort study Tracking Adolescents' Individual Lives Survey (TRAILS), conducted from September 1, 2005, to December 31, 2016, among females aged 16 to 25 years who had filled out at least 1 and up to 4 assessments of oral contraceptive use, were used. Data analysis was performed from March 1, 2017, to May 31, 2019. EXPOSURE: Oral contraceptive use at 16, 19, 22, and 25 years of age. MAIN OUTCOMES AND MEASURES: Depressive symptoms were assessed by the DSM-IV-oriented affective problems scale of the Youth (aged 16 years) and Adult Self-Report (aged 19, 22, and 25 years). RESULTS: Data from a total of 1010 girls (743-903 girls, depending on the wave) were analyzed (mean [SD] age at the first assessment of oral contraceptive use, 16.3 [0.7]; (mean [SD] age at the final assessment of oral contraceptive use, 25.6 [0.6] years). Oral contraceptive users particularly differed from nonusers at age 16 years, with nonusers having a higher mean (SD) socioeconomic status (0.17 [0.78] vs -0.15 [0.71]) and more often being virgins (424 of 533 [79.5%] vs 74 of 303 [24.4%]). Although all users combined (mean [SD] ages, 16.3 [0.7] to 25.6 [0.6] years) did not show higher depressive symptom scores compared with nonusers, adolescent users (mean [SD] age, 16.5 [0.7] years) reported higher depressive symptom scores compared with their nonusing counterparts (mean [SD] age, 16.1 [0.6] years) (mean [SD] score, 0.40 [0.30] vs 0.33 [0.30]), which persisted after adjustment for age, socioeconomic status and ethnicity (β coefficient for interaction with age, -0.021; 95% CI, -0.038 to -0.005; P = .0096). Adolescent contraceptive users particularly reported more crying (odds ratio, 1.89; 95% CI, 1.38-2.58; P < .001), hypersomnia (odds ratio, 1.68; 95% CI, 1.14-2.48; P = .006), and more eating problems (odds ratio, 1.54; 95% CI, 1.13-2.10; P = .009) than nonusers. CONCLUSIONS AND RELEVANCE: Although oral contraceptive use showed no association with depressive symptoms when all age groups were combined, 16-year-old girls reported higher depressive symptom scores when using oral contraceptives. Monitoring depressive symptoms in adolescents who are using oral contraceptives is important, as the use of oral contraceptives may affect their quality of life and put them at risk for nonadherence.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. de Wit AE, Booij SH, Giltay EJ, et al. Association of Use of Oral Contraceptives With Depressive Symptoms Among Adolescents and Young Women. JAMA Psychiatry. 2020. PMID: 31577333. doi:10.1001/jamapsychiatry.2019.2838

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。